Literature DB >> 27317953

Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?

Thiery Chapelle1, Bart Op De Beeck2, Ivan Huyghe3, Sven Francque4, Ann Driessen5, Geert Roeyen6, Dirk Ysebaert6, Kathleen De Greef6.   

Abstract

INTRODUCTION: Posthepatectomy liver failure (PHLF) is a major complication after hepatectomy with a high mortality rate and is likely to happen in insufficient liver remnant. We hypothesize that assessment of the estimated future liver remnant function (eFLRF), combining future remnant liver volume (FLRV) with total liver function (TLF), is an accurate formula for prediction of PHLF.
METHODS: 88 patients undergoing hepatectomy were included. The ratio of the future liver remnant volume (FLRV%) was measured on MRI. TLF was estimated by liver clearance of (99m)Technetium (Tc)-mebrofenin on hepatobiliary scintigraphy (HBS). eFLRF was calculated by multiplying FLRV% by TLF. Cut-off values of FLRV% and eFLRF predicting PHLF, were defined by receiver-operating-characteristic (ROC) analysis.
RESULTS: PHLF occurred in 12 patients (13%). Perioperative mortality was 5/12 (41%). Multivariate analysis showed that FLRV% cut off at 40% was not an independent predictive factor. eFLRF cut off at 2.3%/min/m(2) was the only independent predictive factor for PHLF. For FLRV% vs. eFLRF, positive predictive value was 41% vs. 92% and Odds Ratio 26 vs. 836.
CONCLUSION: FRLF measured by combining FLRV% and TLF is a more valuable tool to predict PHLF than FLRV% alone. The cutoff of eFLRF can be used in clinical decision making.
Copyright © 2015 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27317953      PMCID: PMC4913132          DOI: 10.1016/j.hpb.2015.08.002

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  54 in total

Review 1.  Hepatic malignancies.

Authors:  J I Tsao; J DeSanctis; R L Rossi; R A Oberfield
Journal:  Surg Clin North Am       Date:  2000-04       Impact factor: 2.741

2.  "State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers.

Authors:  Stefan Breitenstein; Carlos Apestegui; Henrik Petrowsky; Pierre Alain Clavien
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

3.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

4.  Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma.

Authors:  T Matsumata; T Kanematsu; K Shirabe; T Sonoda; T Furuta; K Sugimachi
Journal:  Br J Surg       Date:  1990-06       Impact factor: 6.939

Review 5.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

6.  Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test.

Authors:  Deha Erdogan; Bob H M Heijnen; Roelof J Bennink; Mariël Kok; Sander Dinant; Irene H Straatsburg; Dirk J Gouma; Thomas M van Gulik
Journal:  Liver Int       Date:  2004-04       Impact factor: 5.828

Review 7.  [Recent advances in the case management of colorectal cancer liver metastases].

Authors:  Bernard Nordlinger; Stéphane Benoist
Journal:  Bull Acad Natl Med       Date:  2003       Impact factor: 0.144

8.  Predictive indices of morbidity and mortality after liver resection.

Authors:  Rebecca A Schroeder; Carlos E Marroquin; Barbara Phillips Bute; Shukri Khuri; William G Henderson; Paul C Kuo
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

9.  Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy.

Authors:  Roelof J Bennink; Sander Dinant; Deha Erdogan; Bob H Heijnen; Irene H Straatsburg; Arlene K van Vliet; Thomas M van Gulik
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

10.  Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study.

Authors:  Lucas McCormack; Henrik Petrowsky; Wolfram Jochum; Katarzyna Furrer; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more
  17 in total

1.  A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in 90Y Radioembolization.

Authors:  Sandra van der Velden; Manon N G J A Braat; Tim A Labeur; Mike V Scholten; Otto M van Delden; Roelof J Bennink; Hugo W A M de Jong; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

2.  Optimal use of hepatobiliary scintigraphy before liver resection.

Authors:  Pim B Olthof; Thomas M van Gulik; Roelof J Bennink
Journal:  HPB (Oxford)       Date:  2016-07-04       Impact factor: 3.647

3.  Liver function: homogenous or not?

Authors:  Emmanuel Deshayes; Boris Guiu
Journal:  HPB (Oxford)       Date:  2016-09-13       Impact factor: 3.647

4.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

5.  Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization.

Authors:  Shin Miura; Atsushi Kanno; Koji Fukase; Yu Tanaka; Ryotaro Matsumoto; Tatsuhide Nabeshima; Seiji Hongou; Tetsuya Takikawa; Shin Hamada; Kiyoshi Kume; Kazuhiro Kikuta; Kei Nakagawa; Michiaki Unno; Atsushi Masamune
Journal:  Surg Endosc       Date:  2019-05-06       Impact factor: 4.584

6.  Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green.

Authors:  Pei-Chun Wu; Lun-Zhang Guo; Shan Yu; Ning Zeng; Yu-Cheng Liu; Jia Yu; Zhiming Zhang; Ke Lu; Liangyu Sun; Chunfei Wang; Yu-Han Chang; Yin-Lin Lu; Yu-Fang Shen; Sheng Tai; Yueh-Hsun Chuang; Ja-An Annie Ho; Kai-Wen Huang; Yao-Ming Wu; Tzu-Ming Liu
Journal:  Biomed Opt Express       Date:  2022-03-10       Impact factor: 3.562

Review 7.  Optimization of the future remnant liver: review of the current strategies in Europe.

Authors:  Riccardo Memeo; Maria Conticchio; Emmanuel Deshayes; Silvio Nadalin; Astrid Herrero; Boris Guiu; Fabrizio Panaro
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

Review 8.  Current Modalities for the Assessment of Future Remnant Liver Function.

Authors:  Fadi Rassam; Pim B Olthof; Roelof J Bennink; Thomas M van Gulik
Journal:  Visc Med       Date:  2017-11-30

9.  99mTc-mebrofenin hepatobiliary scintigraphy and volume metrics before liver preparation: correlations and discrepancies in non-cirrhotic patients.

Authors:  Boris Guiu; Emmanuel Deshayes; Fabrizio Panaro; Florian Sanglier; Caterina Cusumano; Astrid Herrerro; Olivia Sgarbura; Nicolas Molinari; François Quenet; Christophe Cassinotto
Journal:  Ann Transl Med       Date:  2021-05

10.  Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver.

Authors:  Carole Allimant; Emmanuel Deshayes; Marilyne Kafrouni; Lore Santoro; Delphine de Verbizier; Marjolaine Fourcade; Christophe Cassinotto; Margaux Hermida; Chloé Guillot; Denis Mariano-Goulart; Boris Guiu
Journal:  Diagnostics (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.